Resolution 210043
Honoring and recognizing Dr. Kizzmekia Corbett for her leadership and achievement on the National Institutes of Health’s COVID-19 vaccine research.
Introduced by
From the floor
Passages in the official transcripts that cite this file number. Every quote links to its exact place in the record.
“210028, entitled a "Resolution authorizing the Philadelphia Land Bank to dispose of 4257 North Fairhill Street located in the 7th Councilmanic District"; and Resolution No. 210029, entitled a "Resolution authorizing the Philadelphia Land Bank to dispose of 4338 Tackawanna Street located in the 7th Councilmanic District"; and Resolution No. 210035, entitled a "Resolution recognizing the outstanding work of Deborah Dia…”
Chief Clerk · Stated Meeting, February 4, 2021 · Feb 4, 2021 · official transcript, this passage
Status timeline
- Jan 28, 2021Introduced and Ordered Placed On Next Week's Final Passage Calendar · CITY COUNCIL
- Feb 4, 2021ADOPTED · CITY COUNCIL
Official documents
Documents open on the City of Philadelphia’s legislative site.
Full text
Read the full text as published
..Title Honoring and recognizing Dr. Kizzmekia Corbett for her leadership and achievement on the National Institutes of Health's COVID-19 vaccine research. ..Body WHEREAS, Dr. Kizzmekia Corbett is a 34-year-old African-American viral immunologist, and one of the key scientists behind the Moderna coronavirus vaccine. She has 15 years of expertise studying dengue virus, respiratory syncytial virus, influenza virus, and coronaviruses. She is a research fellow and the scientific lead for the Coronavirus Vaccines & Immunopathogenesis Team at the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases, Vaccine Research Center (VRC); and WHEREAS, Dr. Corbett received a B.S. in Biological Sciences, with a secondary major in Sociology, in 2008 from the University of Maryland - Baltimore County, where she was a Meyerhoff Scholar and an NIH undergraduate scholar. She obtained her Ph.D. in Microbiology and Immunology in 2014 from the University of North Carolina at Chapel Hill; and WHEREAS, Dr. Corbett's work and expertise focuses on developing novel coronavirus vaccines, including mRNA-1273, a leading candidate vaccine against the virus that causes COVID-19; and WHEREAS, In response to the ongoing global COVID-19 pandemic, the vaccine concept incorporated in mRNA-1273 was designed by Dr. Corbett's team from viral sequence data and rapidly deployed to industry partner, Moderna, Inc., for U.S. Food and Drug Administration (FDA)-approved Phase 1 clinical trial, which unprecedently began only 66 days from the viral sequence release; and WHEREAS, Alongside mRNA-1273, Dr. Corbett's team boasts a portfolio that also includes universal coronavirus vaccine concepts and novel therapeutic antibodies. Additionally, Dr. Corbett spent several years working on a universal influenza vaccine, which is slated for Phase 1 clinical trial; and WHEREAS, Dr. Corbett is also an active member of the NIH Fellows Committee and avid advocator of STEM education and vaccine awareness in the community. Her understanding of sociocultural issues and her knowledge of science has made her an influential person in the scientific community; and WHEREAS, Dr. Corbett is an expert on the front lines of the global race for a SARS-CoV-2 vaccine, and will go down in history as one of the key players in developing the science that could end the ongoing global COVID-19 pandemic; now, therefore, be it RESOLVED, BY THE COUNCIL OF THE CITY OF PHILADELPHIA, That it hereby honors and recognizes Dr. Kizzmekia Corbett for her leadership on the National Institutes of Health's COVID-19 vaccine research. ..End